Fatty Liver and Type 2 Diabetes? Try a Weekly Injection Study

Please fill in your details

Please enter first name.

Please enter last name.

Please enter valid email.

Please enter valid contact number.

Please select type of diabetes.

About the Study

This study is for adults diagnosed with Type 2 Diabetes and fatty liver disease caused by MASH, sometimes called “fatty liver.” It focuses on people with liver cirrhosis due to MASH and aims to test the safety and effectiveness of a once-weekly injection of an investigational medication as a potential treatment.

Join the study if you meet the following requirements:

Diagnosed with MASH (or ‘Fatty Liver’) Cirrhosis.
Willing to have a liver biopsy performed.
BMI greater than 27
A1c less than 10%.

Please fill in your details

Please enter first name.

Please enter last name.

Please enter valid email.

Please enter valid contact number.

Please select type of diabetes.